An interactive Webinar with Long Term Care (LTC) physicians, nurses and pharmacists across Canada regarding the history, prevalence and criteria for diagnosis of PTSD along with the neurophysiology behind the condition. Current treatment options will be reviewed along with efficacy and limitations in therapy. Emphasis on the dysfunction of the endocannabinoid system will be explored with cannabinoid supplementation being a potential therapeutic option. The clinical evidence behind the use of medical cannabis for PTSD will also be examined including a focus on managing seniors in LTC facilities.